John R. Packer
Notch signalling is a potential resistance mechanism of progenitor cells within patient‐derived prostate cultures following ROS‐inducing treatments
Packer, John R.; Hirst, Adam M.; Droop, Alastair P.; Adamson, Rachel; Simms, Matthew S.; Mann, Vincent M.; Frame, Fiona M.; O'Connell, Deborah; Maitland, Norman J.
Adam M. Hirst
Alastair P. Droop
Matthew S. Simms
Vincent M. Mann
Dr Fiona Frame F.Frame@hull.ac.uk
Lecturer in Cancer Biology
Norman J. Maitland
Low Temperature Plasma (LTP) generates reactive oxygen and nitrogen species, causing cell death, similarly to radiation. Radiation resistance results in tumour recurrence, however mechanisms of LTP resistance are unknown. LTP was applied to patient‐derived prostate epithelial cells and gene expression assessed. A typical global oxidative response (AP‐1 and Nrf2 signalling) was induced, whereas Notch signalling was activated exclusively in progenitor cells. Notch inhibition induced expression of prostatic acid phosphatase (PAP), a marker of prostate epithelial cell differentiation, whilst reducing colony forming ability and preventing tumour formation. Therefore, if LTP is to be progressed as a novel treatment for prostate cancer, combination treatments should be considered in the context of cellular heterogeneity and existence of cell type‐specific resistance mechanisms.
|Journal Article Type||Article|
|Publication Date||Aug 30, 2019|
|Peer Reviewed||Peer Reviewed|
|APA6 Citation||Packer, J. R., Hirst, A. M., Droop, A. P., Adamson, R., Simms, M. S., Mann, V. M., …Maitland, N. J. (2019). Notch signalling is a potential resistance mechanism of progenitor cells within patient‐derived prostate cultures following ROS‐inducing treatments. FEBS Letters, https://doi.org/10.1002/1873-3468.13589|
|Keywords||Low temperature plasma; Notch signalling; Progenitor cells; Prostate cancer; Reactive oxygen species; Therapy resistance|
|Related Public URLs||http://eprints.whiterose.ac.uk/150977/|
|Additional Information||Received: 2019-05-29; Accepted: 2019-08-08; Published: 2019-09-17|
© 2019 The Authors. FEBS Letters published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
You might also like
Effects on prostate cancer cells of targeting RNA polymerase III
Phenotype-independent DNA methylation changes in prostate cancer